ArticleScientific reports2024

C-reactive protein as robust laboratory value associated with prognosis in patients with stage III non-small cell lung cancer (NSCLC) treated with definitive radiochemotherapy.

Cedric Richlitzki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.